Evidence map›Paper›PMID 29909039›Full record

ArticleBiomaterials2018

Integrin α

A D Schwartz, C L Hall, L E Barney, C C Babbitt, S R Peyton

Abstract read
In one paragraph

Article in Biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Beyond the membrane: rethinking EGFR signaling in physiology and cancer.Cellular and molecular life sciences : CMLS · 2026
    Review
  4. Article
  5. Cell-Instructive Biomaterials with Native-Like Biochemical Complexity.Annual review of biomedical engineering · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A D SchwartzDepartment of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA, 01003, USA.
C L HallDepartment of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA, 01003, USA.
L E BarneyDepartment of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA, 01003, USA.
C C BabbittDepartment of Biology, University of Massachusetts Amherst, Amherst, MA, 01003, USA.
S R PeytonDepartment of Chemical Engineering, University of Massachusetts Amherst, Amherst, MA, 01003, USA. Electronic address: speyton@ecs.umass.edu.
University of Massachusetts Amherst · US

Funding

CHEMISTRY-BIOLOGY INTERFACE PREDOCTORAL TRAINING GRANTST32GM008515 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI THOMPSON, LYNMARIE K. · 1995 to 2020
$4.3M
Tissue-specific stem cells and breast cancer tissue tropism in bioengineered microenvironmentsDP2CA186573 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI PEYTON, SHELLY R. · 2013 to 2015
$2.6M
NCI NIH HHS DP2 CA186573NIGMS NIH HHS T32 GM008515
6 · The paper itself

Abstract

Cells sense and respond to mechanical cues from the extracellular matrix (ECM) via integrins. ECM stiffness is known to enhance integrin clustering and response to epidermal growth factor (EGF), but we lack information on when or if these mechanosensitive growth factor receptors and integrins converge intracellularly. Towards closing this knowledge gap, we combined a biomaterial platform with transcriptomics, molecular biology, and functional assays to link integrin-mediated mechanosensing and epidermal growth factor receptor (EGFR) signaling. We found that high integrin α

Indexed as

Mechanotransduction, CellularCalpainCell Line, TumorCell MovementEpidermal Growth FactorErbB ReceptorsHumansIntegrin alpha6LamininCalpainEpidermal Growth FactorErbB ReceptorsIntegrin alpha6LamininBiomaterialsCell motilityExtracellular matrixLamininPoly(ethylene glycol)Stiffness

Identifiers

PMID29909039
PMCPMC6211197
OpenAlexW2807221590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.